Company Active LTD

Company profile

Senti Tech Limited

Senti - Landing Page - Senti.care

Senti is a clinical services and technology company - meaning we both provide direct patient care and develop technology to improve care.

CRN
11112954
Founded
2017
Age
8

Overview

Legal name
SENT2943 LIMITED
Region
East of England
Registered address
PROSPECT HOUSE
ROUEN ROAD
NORWICH
NR1 1RE
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Senti Tech Limited
CRN 11112954
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

7 events
21 Dec
2024

Confirmation statement due

Confirmation Due

Next confirmation statement due date

07 Nov
2024

Change Of Name Notice

Change-of-name

CONNOT | Transaction MzQ0MjM3NDY1NGFkaXF6a2N4 | Paper/PDF filed

Published 16 Nov 2024 04:10

07 Nov
2024

Certificate Change Of Name Company

Change-of-name

CERTNM | Transaction MzQ0MjM3NTc2OGFkaXF6a2N4 | Paper/PDF filed

Published 16 Nov 2024 03:33

30 Sep
2024

Accounts due

Accounts Due

Next accounts due date

07 Dec
2023

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2022

Accounts filed

Accounts

Last accounts made up date

15 Dec
2017

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2022
Funded years
2022, 2023
Age at first award
4 years

Projects

2023 Launchpad Lead participant

Supply-Works - Unlocking the power of network effects for supplier intelligence and visibility in the medical devices sector

1 Sep 2023 to 29 Feb 2024

Awarded
£97,821
Total cost £97,821

**Background**: SMEs are particularly vulnerable to supply chain disruption. Supplier management takes up considerable time and energy for the whole team and presents significant risks to business continuity and viability. SMEs face further challenges through a lack of leverage in supplier relationships (lower-valued orders), competing against larger, bett...

2023 Collaborative R&D Lead participant

Arthritect: Advancing Precision Medicine of Inflammatory Arthritides through inflammatory biomarker sensing technology

1 Aug 2023 to 31 May 2025

Awarded
£468,895
Total cost £669,850

**Background:** Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are debilitating conditions that affect 1-2% of people. Irreversible joint damage builds up the longer these conditions remain ineffectively managed or untreated. Over 1-in-3 people with these conditions have to stop work within two years of symptoms starting. Yet, it takes over 6 mon...

2022 Collaborative R&D Lead participant

Research and Development of Senti-AI: Tech-enabled precision & predictive respiratory medicine leveraging an innovative wearable medical device

1 Apr 2022 to 30 Jun 2023

Awarded
£277,659
Total cost £396,655

**Background**: Imagine what the world would be like for the 500 million people globally suffering with long-term respiratory illnesses, if their lungs could tell them exactly what was wrong, how their illness was progressing, and precisely what to do about it? Well, they can: the problem is we've been listening to what the lungs can tell us, for the past...

Product types

Collaborative R&D Launchpad